Literature DB >> 10717232

The c-Jun N-terminal kinase pathway and apoptotic signaling (review).

Y R Chen1, T H Tan.   

Abstract

The c-Jun N-terminal kinase (JNK) group of mitogen-activated protein kinases (MAPKs) is activated in mammalian cells by environmental stress, pro-inflammatory cytokines, and mitogenic stimuli. Biochemical and genetic studies demonstrate that JNK regulates the activities of many transcription factors, and that the JNK pathway is required for the regulation of inflammatory responses, cell proliferation, and apoptosis. The involvement of JNK in apoptotic cell death is particularly intriguing, and has been actively studied in recent years. An improved understanding of JNK-mediated apoptotic signaling may provide novel strategies in prevention and treatment of cancers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717232     DOI: 10.3892/ijo.16.4.651

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  42 in total

1.  Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes.

Authors:  Hideya Mizuno; Yong-Yeon Cho; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-01       Impact factor: 4.784

2.  Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.

Authors:  Bing-Sheng Li; Lei Zhang; Satoru Takahashi; Wu Ma; Howard Jaffe; Ashok B Kulkarni; Harish C Pant
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  MicroRNA-98-5p regulates the proliferation and apoptosis of A549 cells by targeting MAP4K3.

Authors:  Ziquan Wang; Zhengxiang Han; Lansheng Zhang; Shiqiang Zhang; Baoqing Wang
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

4.  Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt.

Authors:  J Størling; J Binzer; A K Andersson; R A Züllig; M Tonnesen; R Lehmann; G A Spinas; S Sandler; N Billestrup; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-08-25       Impact factor: 10.122

5.  Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.

Authors:  Jinhua Wang; Isere Kuiatse; Adrian V Lee; Jingxuan Pan; Armando Giuliano; Xiaojiang Cui
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

6.  Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.

Authors:  Shala L Thomas; Jing Zhao; Zijian Li; Bin Lou; Yuhong Du; Jamie Purcell; James P Snyder; Fadlo R Khuri; Dennis Liotta; Haian Fu
Journal:  Biochem Pharmacol       Date:  2010-07-06       Impact factor: 5.858

7.  Lose and gain: impacts of ERK5 and JNK cascades on each other.

Authors:  Sundaramurthy Pandurangan; Sunita Gakkhar
Journal:  Syst Synth Biol       Date:  2010-07-29

8.  Hsp70 inhibits aminoglycoside-induced hearing loss and cochlear hair cell death.

Authors:  Mona Taleb; Carlene S Brandon; Fu-Shing Lee; Kelly C Harris; Wolfgang H Dillmann; Lisa L Cunningham
Journal:  Cell Stress Chaperones       Date:  2009-01-15       Impact factor: 3.667

9.  Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways.

Authors:  Renee D Read; Erika A Bach; Ross L Cagan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Arrestins in apoptosis.

Authors:  Seunghyi Kook; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.